Trials / Terminated
TerminatedNCT00777842
Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery
Silencing the c-Myc Gene Using Third Generation Antisense Restenosis Therapy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The GTX™ Drug Eluting Coronary Stent System is intended for the treatment of patients with a lesion in the coronary artery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GTX™ Drug Eluting Coronary Stent System | Drug eluting stent |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-10-22
- Last updated
- 2015-12-31
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00777842. Inclusion in this directory is not an endorsement.